Clinical Trials Logo

Fibromyalgia clinical trials

View clinical trials related to Fibromyalgia.

Filter by:

NCT ID: NCT04606095 Recruiting - Healthy Volunteers Clinical Trials

Explosive Synchronization of Brain Network Activity in Chronic Pain

Start date: November 13, 2020
Phase: N/A
Study type: Interventional

This project is being conducted to evaluate the impact of explosive synchronization (ES) and its treatment with non-invasive brain stimulation in fibromyalgia (FM). The study design has three components, however, only 2 aims are enrolling participants. The first part (Aim1) is a cross sectional assessment of brain network explosive synchronization activity, connectivity, and response to pain in healthy controls and age and sex-matched fibromyalgia patients; the third part (Aim 3) is a longitudinal assessment of fibromyalgia patients undergoing one week of sham followed by high-definition transcranial direct current stimulation (HD-tDCS) of the motor cortex (M1) or one week of ES HD-tDCS of a brain region identified from computer modelling (Aim 2).

NCT ID: NCT04599348 Recruiting - Fibromyalgia Clinical Trials

Treatment of CFS and Fibromyalgia With HRG 80 Red Ginseng

Start date: October 14, 2020
Phase: Early Phase 1
Study type: Interventional

Will a unique form of ginseng be clinically helpful in those with chronic fatigue syndrome and fibromyalgia?

NCT ID: NCT04598243 Recruiting - Fibromyalgia Clinical Trials

Treatment of Fibromyalgia and CFS With Ribose, Ashwagandha, Rhodiola, Licorice, Schisandra and Green Tea Extract

Start date: October 14, 2020
Phase: Early Phase 1
Study type: Interventional

Is a combination of Ribose, Ashwagandha, Rhodiola, Schisandra, licorice, and green tea extract helpful in CFS and FIbromyalgia?

NCT ID: NCT04571853 Recruiting - Fibromyalgia Clinical Trials

New Educational Tool for FM

Start date: September 21, 2020
Phase: N/A
Study type: Interventional

This study aims at analyzing the usefulness of a new educational tool developed by Pain Revolution, a compendium of 9 fact sheets along with a related quiz in patients from the Hospital Vall d'Hebron of Barcelona suffering from fibromyalgia, compared to a non-education group. The present study also aims at comparing the usefulness of the new tool based on PNE in two different formats: read and explained.

NCT ID: NCT04571528 Recruiting - Fibromyalgia Clinical Trials

Effectiveness of VIRTUAL FIBROWALK STUDY

Start date: September 21, 2020
Phase: N/A
Study type: Interventional

The main objective of this study is to analyse the effectiveness of the VIRTUAL FIBROWALK multicomponent treatment program as coadjuvant of treatment-as-usual (TAU) compared to TAU alone. In this Randomized Controlled Trial (RCT), in addition to evaluating the clinical effects of VIRTUAL FIBROWALK treatment in the short- and longterm.

NCT ID: NCT04554784 Recruiting - Fibromyalgia Clinical Trials

Effectiveness of Bowen Therapy for Pain Management in Patients With Fibromyalgia

Start date: September 6, 2020
Phase: N/A
Study type: Interventional

The aim of this prospective, randomized study is to explore the effectiveness of Bowen Therapy in pain management for patients with fibromyalgia. In Hong Kong, Bowen Therapy is a non-invasive technique and one of the treatment modalities adopted by Occupational Therapists. Bowen Therapy uses specific sequences of gentle cross-fibre moves over muscles, tendons, ligaments, and fascia to stimulate or improve the flow of blood and lymph, and thus activate the body's healing mechanisms that enhances tissue repair. As a result, it can lessen pain and tension, restore more optimal body function, and subsequently alleviate emotional and psychological stress associated with the pain. Bowen Therapy is widely recognized and utilized worldwide for acute and chronic health conditions from new-born to the elderly, both mobilized and bed-ridden patients with no documented evidence to show it has caused any harm or adverse effects. There are two study groups in this study and patients will be randomized and allocated to either one. One group (Control group) will continue receiving conventional treatment; while another group (Bowen group) will receive 8 sessions of Bowen therapy. The investigators hypothesize that Bowen Therapy is superior to the conventional pain treatment for patients with fibromyalgia.

NCT ID: NCT04546490 Recruiting - Neck Pain Clinical Trials

Effects of Release and Ischemic Pressure of Trigger Points on Neck Pain. A Crossover, Controlled and Randomized Trial.

Start date: February 15, 2020
Phase: N/A
Study type: Interventional

The aim of the study is to compare two manual therapy techniques. By testing if the Pressure Release of Myofascial Trigger Points technique (PRM) is more effective in treating Myofascial Trigger Points present in the upper trapezius muscle of patients with mechanical cervical pain. This will be compared mainly with another manual therapy technique that presents evidences such as Ischemic Pressure technique (IP), and a control group, through the evaluation of the Visual Analogical Scale (VAS), the Threshold of Pain at Pressure (TPP) and the Northwick Park Questionnaire (NPC) of neck disability, spanish version.

NCT ID: NCT04510181 Recruiting - Fibromyalgia Clinical Trials

Effect of an Amino-Acid-Based Blend on Human Growth Hormone (hGH) and Fibromyalgia (FM) Symptoms

Start date: August 1, 2020
Phase: N/A
Study type: Interventional

The purpose of the study is to investigate the effect of the amino acid-based blend on growth hormone levels (measured by IGF-1) and clinical symptoms in individuals with treatment-resistant FM and low-normal hGH.

NCT ID: NCT04500444 Recruiting - Fibromyalgia Clinical Trials

Effects of Aerobic Exercise Training With and Without Blood Flow Restriction in Fibromyalgia

Start date: November 13, 2019
Phase: N/A
Study type: Interventional

In our study, we aimed to evaluate and compare the effects of low-intensity aerobic exercise training with blood flow restriction and without blood flow restriction, on pain, functional status, quality of life and catecholamine metabolite levels in 24-hour urine in adults with Fibromyalgia.

NCT ID: NCT04436250 Recruiting - Fibromyalgia Clinical Trials

ESKETamine for FIBromyalgia Treatment

ESKEFIB
Start date: October 10, 2020
Phase: N/A
Study type: Interventional

Fibromyalgia is a cause of chronic pain, classified by the Internal Classification of Diseases (ICD) as a primary chronic pain with specific diagnostic criteria established by the American College of Rheumatology (ACR). No treatment to its complete cure is available at this time, all treatments having as purpose pain relief and an improvement of quality of life by combining pharmacologic and nonpharmacologic treatments. One of the mechanisms proposed in fibromyalgia is the central sensitisation phenomenon, by which the central nervous system becomes "hypersensitive" to nociceptive or non-nociceptive stimuli. The receptor involved in this phenomenon is the N-methyl-D-aspartate receptor to which ketamine binds. Ketamine has therefore been proposed as a co-treatment in chronic pain with central sensitization phenomena, such as fibromyalgia.